0.25p+0.00 (+0.00%)17 Apr 2025, 16:00
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Kanabo Group PLC Fundamentals

Company NameKanabo Group PLCLast Updated2025-04-17
IndustryMedical Care FacilitiesSectorHealthcare
Shares in Issue632.428 mMarket Cap£1.58 m
PE Ratio0.03Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.01EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0300Debt Equity Ratio0.0123
Asset Equity Ratio1.1613Cash Equity Ratio0.2613
Quick Ratio2.1045Current Ratio2.78
Price To Book Value0.2669ROCE0

Kanabo Group PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Kanabo Group PLC Company Financials

Assets20232022
Tangible Assets£49,000.00£378,000.00
Intangible Assets£4.73 m£10.04 m
Investments00
Total Fixed Assets£4.78 m£10.45 m
Stocks£56,000.00£81,000.00
Debtors£257,000.00£107,000.00
Cash & Equivalents£1.68 m£3.69 m
Other Assets00
Total Assets£8.35 m£14.45 m
Liabilities20232022
Creditors within 1 year£710,000.00£1.50 m
Creditors after 1 year£139,000.00£510,000.00
Other Liabilities00
Total Liabilities£849,000.00£2.01 m
Net assets£7.50 m£12.45 m
Equity20232022
Called up share capital£15.81 m£10.57 m
Share Premium£7.25 m£6.85 m
Profit / Loss-£8.00 m-£6.87 m
Other Equity£7.51 m£12.45 m
Preference & Minorities-£11,000.00-£3,000.00
Total Capital Employed£7.50 m£12.45 m
Ratios20232022
Debt Ratio£0.02£0.04
Debt-to-Equity£0.02£0.04
Assets / Equity1.16131.1613
Cash / Equity0.26130.2613
EPS-£0.01-£0.01
Cash Flow20232022
Cash from operating activities-£2.52 m-£3.78 m
Cashflow before financing£45,000.00-£1.38 m
Increase in Cash-£1.65 m-£1.30 m
Income20232022
Turnover£895,000.00£603,000.00
Cost of sales£761,000.00£404,000.00
Gross Profit£134,000.00£199,000.00
Operating Profit-£7.79 m-£6.78 m
Pre-Tax profit-£8.00 m-£6.87 m

Kanabo Group PLC Company Background

SectorHealthcare
ActivitiesKanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Careand Secondary Care. The Primary Care segment, which derives key revenue, includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom and Israel.
Latest Interim Date30 Sep 2024
Latest Fiscal Year End Date30 Apr 2025

Kanabo Group PLC Directors

AppointedNamePosition
2023-05-08Mr. Gil Efron, C.P.A.,M.A.Non-Executive Director
2018-10-15Mr. Richard Thomas Liddell Executive Director
2025-03-24Mr. Ian Thomas Mattioli MBENon-Executive Director,Chairman
2024-05-07Mr. Andrew John Gowdy MorrisonNon-Executive Director,Chairman
2019-05-21Mr. Jonathan Bradley-Hoare Executive Director,Finance Director
2025-01-30Mr. David TsurNon-Executive Director,Deputy Chairman
2024-05-07Mr. Sharon MalkaNon-Executive Director
2021-06-07Mr. Anthony James HarpurNon-Executive Director
2021-06-07Mr. Alan Douglas HumeNon-Executive Director
2023-05-02Mr. Uziel DaninoNon-Executive Director
2024-05-07Mr. Avihu TamirExecutive Director,Chief Executive Officer
2023-05-08Dr. Daniel Poulter MPNon-Executive Director

Kanabo Group PLC Contact Details

Company NameKanabo Group PLC
Address59-60 Russell Square, London, WC1B 4HP
Telephone+44 7980878561
Websitehttps://www.kanabogroup.com

Kanabo Group PLC Advisors

Financial AdviserSP Angel
Phone+44 2034700470
Fax+44 2076291341
SolicitorBishop & Sewell LLP
Phone+44 2076314141
AuditorAdler Shine LLP
Phone+44 2083713000
Fax+44 2083713099
BankMetro Bank Plc
RegistrarNeville Registrars Ltd
Phone+44 1215851131
Fax+44 1215851132
StockbrokerSP Angel
Phone+44 2034700470
Fax+44 2076291341